A price

$23.66$0.00 (+0.00%)
Last updated on --.

About A

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Stock ticker
A
Company
Agilent Technologies, Inc.
Industry
Healthcare
Category
US
Stock split / reverse split
500699
Launch date
Nov 18, 1999
Listed exchange
NYSE

Financials

Q3 FY2026 Earnings
Report period: Jul 31, 2026 – Jul 31, 2026

Summary: A reported Revenue of 1.88B (+8.06%), beating expectations; EPS of 1.62 (+18.25%), beating expectations.

Revenue (USD)Beat1.88B+8.05%1.84B+9.31%36.49M+1.98%
EPS (USD)Beat1.62+18.24%1.49+8.75%0.13+8.72%
Financial estimates
● Actual● Estimate
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
1.181.531.071.201.28
+21.64%+25.40%-3.61%+60.00%+8.47%
● EPS● YoY
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
12.23B12.73B12.81B13.07B13.97B
5.86B5.99B5.91B5.94B6.60B
47.89%47.03%46.08%45.48%47.28%
● Assets● Liabilities● Ratio
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
362.00M545.00M268.00M277.00M519.00M
-19.92%+13.30%-37.82%+25.33%+43.37%
● CFO● YoY

Shareholders

Shareholders
BLACKROCK, INC.9.07%
VANGUARD CAPITAL MANAGEMENT LLC6.54%
VANGUARD PORTFOLIO MANAGEMENT LLC5.12%
STATE STREET CORP4.54%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/3.55%
Others71.16%
Institutions
% Owned93.25%+3.45%
Shares held263.91M+9.79M
Institutions1,166+56
% OwnedPrice
Name% OwnedChange
BLACKROCK, INC.9.07%-303.66K
VANGUARD CAPITAL MANAGEMENT LLC6.54%+68.83K
VANGUARD PORTFOLIO MANAGEMENT LLC5.12%+89.76K
STATE STREET CORP4.54%+89.60K
MASSACHUSETTS FINANCIAL SERVICES CO /MA/3.55%-2.61M

Dividends

Dividends
Last ex-dividend: Oct 6, 2026 Cash dividend: 0.26 USD per share
Dividend yield TTM
0.60%
Payout ratio LFY
21.70%
Frequency
Quarterly
20222023202420252026
1.070.910.960.741.02
+0.57%+0.65%+0.71%+0.77%+0.60%
Dividend amount (USD)Dividend yield
Stock splits
Launch date: Nov 18, 1999
DateRatio
Nov 3, 2014500 → 699
Trade on the go with the OKX app

A performance

$23.66
A price today

A price today is $23.66, marking a +0.00% over the past 24 hours. On OKX, today’s A trading volume reached --, worth over --.

$23.66
A in USD

The current A to USD conversion rate is $23.66 per A.

More to explore

FAQ

A is trading at $23.66, +0.00% over the last 24 hours. Track live moves on the price chart at the top of this page.

The A stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. A is currently trading at $23.66, +0.00% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on A price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.

P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. A's P/E ratio is currently 33.03 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from A; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against A's historical range and other companies in the Healthcare sector.

Agilent Technologies, Inc.'s market cap is currently 47.38B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.